1,100
Participants
Start Date
August 14, 2024
Primary Completion Date
October 31, 2026
Study Completion Date
January 31, 2027
Bexsero
Administered as an IM injection by 0.5-mL single-dose syringe at enrollment (Visit 1) and 2 months post-enrollment (Visit 3).
Placebo
Administered as an IM injection by 0.5-mL single-dose syringe at enrollment (Visit 1) and 2 months post-enrollment (Visit 3).
Desmond Tutu Health Foundation - Emavundleni Research Centre, Cape Town
Desmond Tutu Health Foundation - Masiphumulele Site, Cape Town
Khayelitsha Vuka Research Clinic, Cape Town
Wits RHI Ward 21 Clinical Research Site, Johannesburg
Center for Community Based Research (CCBR), Pietermaritzburg
Bill and Melinda Gates Foundation
OTHER
University of Witwatersrand, South Africa
OTHER
University of Washington
OTHER